Melissa Angelini
Investor Relations Contact bij PROCAPS GROUP S.A.
Profiel
Melissa Angelini is currently the Director-Investor Relations at Procaps Group SA since 2022.
Prior to this, she worked as the Head-Investor Relations at Blau Farmacêutica SA and as the Manager-Investor Relations at Biotoscana Investments SA from 2017 to 2019.
Ms. Angelini completed her undergraduate degree at Universidad de Palermo and her MBA at Insper Institute of Education & Research.
Actieve functies van Melissa Angelini
| Bedrijven | Functie | Begin |
|---|---|---|
| PROCAPS GROUP S.A. | Investor Relations Contact | 01-02-2022 |
Eerdere bekende functies van Melissa Angelini
| Bedrijven | Functie | Einde |
|---|---|---|
| BLAU FARMACÊUTICA S.A. | Public Communications Contact | - |
| BIOTOSCANA INVESTMENTS S.A. | Investor Relations Contact | - |
Opleiding van Melissa Angelini
| Universidad de Palermo | Undergraduate Degree |
| Insper Institute of Education & Research | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BLAU FARMACÊUTICA S.A. | Health Technology |
| PROCAPS GROUP S.A. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Biotoscana Investments SA
 Biotoscana Investments SA Pharmaceuticals: MajorHealth Technology Biotoscana Investments SA operates as a holding company, which engages in the development, manufacturing and commercialization of advanced medicine. Its operations include oncology, onco-hematology, severe infectious diseases, genetic and rare conditions as well as immunology and inflammation. The company was founded in August 16, 2011 and is headquartered in Montevideo, Uruguay. | Health Technology |
